Prostate cancer screening practices and beliefs

Voss, John D.; Schectman, Joel M.

doi:10.1046/j.1525-1497.2001.10133.x

Cited by 66 publications

(82 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Though PSA was graded as an "I" recommendation by the US Preventive Services Task Force at the time of study data collection, it was increasingly considered the standard of care at the turn of the century. 23 Interestingly, the individual analysis of patient-centeredness failed to show an association with CRC screening, which may indicate that, with counseling, patients feel they can opt out of this screening. Such an interpretation is supported by prior research regarding the effects of shared decision making on patient cancer screening decisions.…”

Section: Discussionmentioning

confidence: 99%

“…[17][18][19][20][21] We used common practice when guidelines were not available or at odds with common practice. 22,23 We included mammography data for female respondents aged Ն40 years and defined adherent as reporting a mammogram within the past 2 years for those Ն50 years and ever reporting a mammogram for those 40 to 49 years old. Papanicolaou testing was included for female respondents aged 21 to 65 years old and was defined as adherent if performed within the past 3 years.…”

Section: Preventive Care Measuresmentioning

confidence: 99%

See 1 more Smart Citation

Primary Care Attributes Associated with Receipt of Preventive Care Services: A National Study

VanGompel

Jerant

Franks

2015

The Journal of the American Board of Family Medicine

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Preventive Care Measuresmentioning

confidence: 99%

Primary Care Attributes Associated with Receipt of Preventive Care Services: A National Study

VanGompel

Jerant

Franks

2015

The Journal of the American Board of Family Medicine

View full text Add to dashboard Cite

“…Following publication of the clinical trials, use in this setting increased dramatically for all groups of urologists, but with a significantly higher rate for urologists without academic affiliation. This may be due to more cautious or selective use of androgen deprivation by academic urologists in response to the evidence (32). In addition, factors other than evidence of benefit may have influenced use of androgen deprivation by urologists without academic affiliation.…”

Section: Discussionmentioning

confidence: 99%

“…Through the 1990s, androgen deprivation use in the form of GnRH agonists allowed a substantial profit for every dose administered, and formed a substantial portion of private practice urologists' income (33,34). Physicians in academic settings may have more time for discussion of risks and benefits, which could lead to lower use of androgen deprivation in settings where its benefits are uncertain (32). Finally, academic physicians may be less influenced by pharmaceutical industry marketing of GnRH agonists (35).…”

Section: Discussionmentioning

confidence: 99%

Characteristics of Urologists Predict the Use of Androgen Deprivation Therapy for Prostate Cancer

Shahinian

Kuo

Freeman

et al. 2007

JCO

View full text Add to dashboard Cite

Purpose-We have previously reported wide variations among urologists in use of androgen deprivation for prostate cancer. Using Surveillance, Epidemiology and End-Results (SEER)-Medicare linked data we examined how individual urologist characteristics influenced use of androgen deprivation therapy.Methods-Participants included 82,375 men with prostate cancer diagnosed from January 1, 1992, through December 31, 2002, and 2,080 urologists providing care to them. Multi-level analyses were used to estimate likelihood of androgen deprivation use within six months of diagnosis in the overall cohort, a subgroup where use would be of uncertain benefit (primary therapy for localized prostate cancer), and a subgroup where use would be evidence-based (adjuvant therapy with radiation for locally advanced disease).Results-In the overall cohort of patients, a multi-level model adjusted for patient, tumor and urologist characteristics (board certification, academic affiliation, patient panel size, years since medical school graduation) showed that the likelihood of androgen deprivation use was significantly higher for patients who saw urologists without an academic affiliation. This pattern was also noted when the analysis was limited to settings where androgen deprivation would have been of uncertain benefit. Odds ratios for use in that context were 1.66 (95%CI: 1.27-2.16) for no academic affiliation and 1.45 (95%CI:1.13-1.85) for minor versus major academic affiliation.Conclusion-Use of androgen deprivation for prostate cancer varies by the characteristics of the urologist. Patients of non-academically affiliated urologists were significantly more likely to receive primary androgen deprivation therapy for localized prostate cancer, a setting where the benefits are uncertain.

show abstract

“…1 The prostate-specific antigen (PSA) test and digital rectal examination (DRE) are screening tools associated with early detection of the disease, and use of these screening tools has increased over the years. 2,3 Emerging research regarding the benefits and harms associated with early detection challenge the frequent use of these tools. 1 Notwithstanding, decisions regarding prostate cancer screening are crucial, particularly for African American men and men with a family history of prostate cancer who are at high risk for the disease.…”

Section: Introductionmentioning

confidence: 99%

Discussions About Prostate Cancer Screening Between U.S. Primary Care Physicians and Their Patients

et al. 2011

View full text Add to dashboard Cite

OBJECTIVE: This study examined the likelihood that U.S. primary care physicians (PCPs) discuss and recommend prostate cancer screening with their patients and physician-related and practice-related factors associated with this behavior. METHODS: We analyzed data from the 2007-2008 National Survey of Primary Care Physician Practices Regarding Prostate Cancer Screening (N=1,256), the most recent and comprehensive survey specifically designed to address issues concerning prostate cancer screening and representing nearly 95,000 PCPs. We evaluated the relationship between PCP behavior regarding prostate cancer screening discussions and covariates, including PCP demographic and practicerelated factors. Weighted percentages and Chi-square tests were used to compare use of screening discussions by PCP characteristics. Adjusted odds of discussing screening and recommending the PSA test were determined from logistic regression. RESULTS: Eighty percent of PCPs reported that they routinely discuss prostate cancer screening with all of their male patients, and 64.1% of PCPs who discussed screening with any patients reported that they attempted to talk their patients into getting the PSA test. In multivariate analyses, encouraging PSA testing was more likely among non-Hispanic black PCPs (OR= 2.80, 95% CI [1.88, 4.16

show abstract

Prostate cancer screening practices and beliefs

Cited by 66 publications

References 25 publications

Primary Care Attributes Associated with Receipt of Preventive Care Services: A National Study

Primary Care Attributes Associated with Receipt of Preventive Care Services: A National Study

Characteristics of Urologists Predict the Use of Androgen Deprivation Therapy for Prostate Cancer

Discussions About Prostate Cancer Screening Between U.S. Primary Care Physicians and Their Patients

Contact Info

Product

Resources

About